Cancer Therapy Could Benefit from Chitosan-Based Nano-Prodrugs

Date 1st, Jun 2022
Source AZoNano - Nanotechnology Websites

DESCRIPTION

Scientists have stated that polysaccharide-based nano-prodrug crosslinked by stimuli-responsive synergetic prodrugs exhibit great tumor selectivity, stability, and synergetic effect. As a result, such...